Semin Respir Crit Care Med 2015; 36(02): 194-206
DOI: 10.1055/s-0035-1546749
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Imaging in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis

Jonathan D. Dodd
1   Department of Radiology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
,
Lisa P. Lavelle
1   Department of Radiology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
,
Aurelie Fabre
2   Department of Pathology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
,
Darragh Brady
1   Department of Radiology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
› Author Affiliations
Further Information

Publication History

Publication Date:
31 March 2015 (online)

Abstract

Bronchiectasis is defined as a permanent and progressive dilation of the airways, typically as a result of inflammation, infection, and subsequent repair. It typically presents with chronic cough, suppurative sputum production, and airway dilation. High-resolution computed tomography (HRCT) is now well established as the primary imaging tool for its investigation. Cystic fibrosis (CF) remains the most common autosomal recessive inherited disorder worldwide and its pulmonary hallmark is bronchiectasis. Although CF and non-CF bronchiectasis are different clinical entities, they are typically imaged using HRCT and share many imaging aspects, and also some differences. Several important recent CT technology developments have improved the detection and characterization of bronchiectasis and its complications. Many CT aspects of radiation exposure have also undergone important enhancements in recent years resulting in significant dose reductions. This is particularly relevant in a pulmonary disease such as bronchiectasis, which often undergoes serial HRCT surveillance in contemporary practice. Several new CT clinical applications in bronchiectasis have been recently advanced, and CT is now being increasingly incorporated into investigative algorithms to assess bronchiectasis treatment effects. In this review, we assess the latest imaging features of CF and non-CF bronchiectasis, discuss radiation dose reducing methods and technology of the latest scanners, describe recent CT clinical applications, and explore the use of CT as a treatment surrogate in CF and non-CF bronchiectasis.

 
  • References

  • 1 Muller NL, Fraser RS, Colamn NC, Pare PD, Radiological Diagnosis of Diseases of the Chest, 1st ed. In: Bralow L. , ed. Philadelphia, PA: W.B. Saunders Company; 2001
  • 2 Webb WR, Muller NL, Naidich DP. High Resolution CT of the Lung, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001
  • 3 Hansell DM, Armstrong P, Lynch DA, McAdams HP. Imaging Diseases of the Chest, 4th ed. London, UK: Elsevier Mosby; 2005
  • 4 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246 (3) 697-722
  • 5 Shah RM, Sexauer W, Ostrum BJ, Fiel SB, Friedman AC. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 1997; 169 (2) 375-380
  • 6 Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening. Hum Mutat 2002; 19 (6) 575-606
  • 7 Hricak H, Brenner DJ, Adelstein SJ , et al. Managing radiation use in medical imaging: a multifaceted challenge. Radiology 2011; 258 (3) 889-905
  • 8 Tamm EP, Rong XJ, Cody DD, Ernst RD, Fitzgerald NE, Kundra V. Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality. Radiographics 2011; 31 (7) 1823-1832
  • 9 Tiddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 2006; 7 (3) 202-208
  • 10 Flohr TG, Schaller S, Stierstorfer K, Bruder H, Ohnesorge BM, Schoepf UJ. Multi-detector row CT systems and image-reconstruction techniques. Radiology 2005; 235 (3) 756-773
  • 11 Dodd JD, Souza CA, Müller NL. Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis. AJR Am J Roentgenol 2006; 187 (2) 414-420
  • 12 Bhalla M, Naidich DP, McGuinness G, Gruden JF, Leitman BS, McCauley DI. Diffuse lung disease: assessment with helical CT—preliminary observations of the role of maximum and minimum intensity projection images. Radiology 1996; 200 (2) 341-347
  • 13 Remy J, Remy-Jardin M, Artaud D, Fribourg M. Multiplanar and three-dimensional reconstruction techniques in CT: impact on chest diseases. Eur Radiol 1998; 8 (3) 335-351
  • 14 Wittram C, Batt J, Rappaport DC, Hutcheon MA. Inspiratory and expiratory helical CT of normal adults: comparison of thin section scans and minimum intensity projection images. J Thorac Imaging 2002; 17 (1) 47-52
  • 15 Eda S, Kubo K, Fujimoto K, Matsuzawa Y, Sekiguchi M, Sakai F. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997; 155 (4) 1290-1294
  • 16 Bankier AA, Mehrain S, Kienzl D, Weber M, Estenne M, Gevenois PA. Regional heterogeneity of air trapping at expiratory thin-section CT of patients with bronchiolitis: potential implications for dose reduction and CT protocol planning. Radiology 2008; 247 (3) 862-870
  • 17 Loeve M, Lequin MH, de Bruijne M , et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?. Radiology 2009; 253 (1) 223-229
  • 18 Kang EY, Miller RR, Müller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 1995; 195 (3) 649-654
  • 19 Loeve M, Hop WC, de Bruijne M , et al; Computed Tomography Cystic Fibrosis Survival Study Group. Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2012; 185 (10) 1096-1103
  • 20 Bauer RW, Schell B, Beeres M , et al. High-pitch dual-source computed tomography pulmonary angiography in freely breathing patients. J Thorac Imaging 2012; 27 (6) 376-381
  • 21 Petersilka M, Bruder H, Krauss B, Stierstorfer K, Flohr TG. Technical principles of dual source CT. Eur J Radiol 2008; 68 (3) 362-368
  • 22 Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231 (2) 440-445
  • 23 Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007; 357 (22) 2277-2284
  • 24 Pearce MS, Salotti JA, Little MP , et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380 (9840) 499-505
  • 25 Mathews JD, Forsythe AV, Brady Z , et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013; 346: f2360
  • 26 Kuo W, Ciet P, Tiddens HAWM, Zhang W, Guillerman RP, van Straten M. Monitoring cystic fibrosis lung disease by computed tomography. Radiation risk in perspective. Am J Respir Crit Care Med 2014; 189 (11) 1328-1336
  • 27 O'Connor OJ, Vandeleur M, McGarrigle AM , et al. Development of low-dose protocols for thin-section CT assessment of cystic fibrosis in pediatric patients. Radiology 2010; 257 (3) 820-829
  • 28 Mott LS, Park J, Murray CP , et al; AREST CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67 (6) 509-516
  • 29 Thrall JH. Radiation exposure in CT scanning and risk: where are we?. Radiology 2012; 264 (2) 325-328
  • 30 Litmanovich DE, Tack DM, Shahrzad M, Bankier AA. Dose reduction in cardiothoracic CT: review of currently available methods. Radiographics 2014; 34 (6) 1469-1489
  • 31 Boone JM, Hendee WR, McNitt-Gray MF, Seltzer SE. Radiation exposure from CT scans: how to close our knowledge gaps, monitor and safeguard exposure—proceedings and recommendations of the Radiation Dose Summit, sponsored by NIBIB, February 24-25, 2011. Radiology 2012; 265 (2) 544-554
  • 32 Ernst CW, Basten IA, Ilsen B , et al. Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels. Radiology 2014; 273 (2) 597-605
  • 33 Singh S, Kalra MK, Gilman MD , et al. Adaptive statistical iterative reconstruction technique for radiation dose reduction in chest CT: a pilot study. Radiology 2011; 259 (2) 565-573
  • 34 de Jong PA, Ottink MD, Robben SG , et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004; 231 (2) 434-439
  • 35 Bhalla M, Turcios N, Aponte V , et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991; 179 (3) 783-788
  • 36 McEvoy S, Lavelle L, Kilcoyne A , et al. High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy. Eur Radiol 2012; 22 (12) 2736-2742
  • 37 Brody AS, Tiddens HA, Castile RG , et al; CT Scanning in Cystic Fibrosis Special Interest Group. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005; 172 (10) 1246-1252
  • 38 Chalmers JD, Goeminne P, Aliberti S , et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 2014; 189 (5) 576-585
  • 39 Judge EP, Dodd JD, Masterson JB, Gallagher CG. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest 2006; 130 (5) 1424-1432
  • 40 de Jong PA, Nakano Y, Lequin MH , et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004; 23 (1) 93-97
  • 41 Owens CM, Aurora P, Stanojevic S , et al; London Cystic Fibrosis Collaboration. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011; 66 (6) 481-488
  • 42 de Jong PA, Lindblad A, Rubin L , et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61 (1) 80-85
  • 43 Tiddens HAWM, Stick SM, Davis S. Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatr Respir Rev 2014; 15 (1) 92-97
  • 44 Wagener JS, Kahn TZ, Copenhaver SC, Accurso FJ. Early inflammation and the development of pulmonary disease in cystic fibrosis. Pediatr Pulmonol Suppl 1997; 16: 267-268
  • 45 Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165 (7) 904-910
  • 46 Pillarisetti N, Williamson E, Linnane B , et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184 (1) 75-81
  • 47 Hayward J, Reid ML. The cartilage of the intrapulmonary bronchi in normal lungs, in bronchiectasis, and in massive collapse. Thorax 1952; 7 (1) 98-110
  • 48 Ogrinc G, Kampalath B, Tomashefski Jr JFJ. Destruction and loss of bronchial cartilage in cystic fibrosis. Hum Pathol 1998; 29 (1) 65-73
  • 49 Baker NR, Tao Y. A tracheal culture model of respiratory tract infection with Pseudomonas aeruginosa. In Vitro 1982; 18 (4) 369-376
  • 50 Tsang KW, Rutman A, Tanaka E , et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 1994; 7 (10) 1746-1753
  • 51 Boiselle PM, Lee KS, Lin S, Raptopoulos V. Cine CT during coughing for assessment of tracheomalacia: preliminary experience with 64-MDCT. AJR Am J Roentgenol 2006; 187 (2) W175-7
  • 52 Boiselle PM, Ernst A. Tracheal morphology in patients with tracheomalacia: prevalence of inspiratory lunate and expiratory “frown” shapes. J Thorac Imaging 2006; 21 (3) 190-196
  • 53 McDermott S, Barry SC, Judge EE , et al. Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT. Radiology 2009; 252 (2) 577-586
  • 54 Koh W-J, Lee KS, Kwon OJ, Jeong YJ, Kwak S-H, Kim TS. Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 2005; 235 (1) 282-288
  • 55 Jeong YJ, Lee KS, Koh W-J, Han J, Kim TS, Kwon OJ. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 2004; 231 (3) 880-886
  • 56 Krustins E, Kravale Z, Buls A. Mounier-Kuhn syndrome or congenital tracheobronchomegaly: a literature review. Respir Med 2013; 107 (12) 1822-1828
  • 57 Shin MS, Jackson RM, Ho KJ. Tracheobronchomegaly (Mounier-Kuhn syndrome): CT diagnosis. AJR Am J Roentgenol 1988; 150 (4) 777-779
  • 58 Woodring JH, Howard II RS, Rehm SR. Congenital tracheobronchomegaly (Mounier-Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging 1991; 6 (2) 1-10
  • 59 Katz I, Levine M, Herman P. Tracheobronchiomegaly. The Mounier-Kuhn syndrome. Am J Roentgenol Radium Ther Nucl Med 1962; 88: 1084-1094
  • 60 Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, Müller NL. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999; 173 (4) 937-942
  • 61 Stevens DA, Moss RB, Kurup VP , et al; Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl. 03) S225-S264
  • 62 Meza Brítez RL, del Río Navarro BE, Ochoa López G, Pietropaolo Cienfuegos D, del Río Chivardi JM, Rosas Vargas MA. [Allergic bronchopulmonary aspergillosis. A report of a case and literature review]. Rev Alerg Mex 2008; 55 (3) 112-116
  • 63 Martínez-García M-A, de la Rosa Carrillo D, Soler-Cataluña JJ , et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187 (8) 823-831
  • 64 Martínez-García M-A, Soler-Cataluña J-J, Donat Sanz Y , et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011; 140 (5) 1130-1137
  • 65 Ramsey BW, Davies J, McElvaney NG , et al; VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365 (18) 1663-1672
  • 66 Hoare S, McEvoy S, McCarthy CJ , et al. Ivacaftor imaging response in cystic fibrosis. Am J Respir Crit Care Med 2014; 189 (4) 484